feed,title,long_url,short_url
🔐MarketWatch,Navidea Biopharmaceuticals rejects ProPhase Labs offer,http://www.marketwatch.com/news/story/navidea-biopharmaceuticals-rejects-prophase-labs/story.aspx?guid=%7B20C06575%2D04D4%2DB545%2D7221%2DBA573AFCA87D%7D&siteid=rss,https://da.gd/yLkMeX
🔐MarketWatch,U.S. stocks open higher after PCE data shows inflation at lowest in over 2 years,http://www.marketwatch.com/news/story/us-stocks-open-higher-after/story.aspx?guid=%7B20C06575%2D04D4%2DB545%2D7221%2DB5A466B50091%7D&siteid=rss,https://da.gd/DOjV
🔐MarketWatch,Bausch + Lomb to buy ‘dry eye’ treatment from Novartis in a $2.5 billion deal,http://www.marketwatch.com/news/story/bausch-lomb-buy-dry/story.aspx?guid=%7B20C06575%2D04D4%2DB545%2D7221%2DB3BE743A227B%7D&siteid=rss,https://da.gd/PY2P1K
🔐MarketWatch,Bausch + Lomb to buy ‘dry eye’ treatment from Novartis in a $2.5 billion deal,http://www.marketwatch.com/news/story/bausch-lomb-buy-dry/story.aspx?guid=%7B20C06575%2D04D4%2DB545%2D7221%2DB2D645BE75AE%7D&siteid=rss,https://da.gd/C7wY
